USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
17 - 20 Jun 2024 | Amsterdam

Missed the exit? Health keeps on trucking despite IPO jam

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

Speakers:

Bryan Sivak Managing PartnerEvidenced
Bryan Sivak
Managing PartnerEvidenced
Cathy Gao PartnerSapphire Ventures
Cathy Gao
PartnerSapphire Ventures
Charlie Bullock CEOScan.com
Charlie Bullock
CEOScan.com
Charlotte Barttelot PrincipalMMC Ventures
Charlotte Barttelot
PrincipalMMC Ventures
Hugh Harvey Managing DirectorHardian Health
Hugh Harvey
Managing DirectorHardian Health

About this Session:

In 2021, health was in cruise control. Ticking over at 130 km/h, with an IPO every few kilometres, a clear road ahead, and not a cloud in the sky. \r\nLooking back as 2020 disappeared in our mirrors we were forging ahead, free to forget about past issues and objections. As we soared up to junction 2022 though, a jam appeared. Just one lane at first, then rapidly filling the highway. \r\nThe skies grew darker. Warning lights started to appear. Slowly at first, then with rapid, debilitating, frequency. Objections in the mirror were indeed closer than they had appeared.\r\nIf you looked just at the public markets, and their reaction to healthtech over the last two years, you could be forgiven for questioning whether an IPO is (still) a legitimate route for the sector.\r\nWith a number of high-profile firms down over 95% from their IPO, many have questioned whether this is indicative of a wider trend in venture-backed healthtech.\r\nAfter the SPAC-attack of 2021, and the subsequent fallout, and with VCs sat on more LP cash than ever before, can healthtech companies really still dream of an IPO? Or should they be set up to explore other exit routes?